Indication
Chronic iron overload due to repeated blood transfusions
Chronic iron overload due to repeated blood transfusions is an acquired systemic disorder characterized by the progressive accumulation of excess iron in parenchymal tissues, occurring in patients requiring long-term transfusion therapy for chronic refractory anemias such as beta-thalassemia, sickle cell disease, or myelodysplastic syndromes. Read more about Chronic iron overload due to repeated blood transfusions
52 drugs 33 manufacturers
Drugs that treat it
Common Chronic iron overload due to repeated blood transfusions therapies.
FERRIPROX (3 TIMES A DAY) (deferiprone)
DEFERASIROX
DEFERIPRONE
DEFERIPRONE (3 TIMES A DAY) (deferiprone)
DEFEROXAMINE MESYLATE
DEFERIPRONE
DEFERIPRONE (3 TIMES A DAY) (deferiprone)
DEFERIPRONE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChronic iron overload due to repeated blood transfusions is an acquired systemic disorder characterized by the progressive accumulation of excess iron in parenchymal tissues, occurring in patients requiring long-term transfusion therapy for chronic refractory anemias such as beta-thalassemia, sickle cell disease, or myelodysplastic syndromes.
Because the human body lacks an active physiologic excretion pathway for excess iron, repeated infusions of donor erythrocytes eventually saturate serum transferrin, resulting in circulating non-transferrin-bound iron.
This unbuffered reactive iron induces cellular oxidative stress and lipid peroxidation, leading to systemic organ injury, predominantly affecting the liver, myocardium, and endocrine glands.
If left untreated, the cumulative toxicity can cause severe end-organ complications, including hepatic fibrosis or cirrhosis, cardiac dysrhythmias and heart failure, and multiple endocrinopathies such as diabetes mellitus and hypogonadism.
- nih.gov
Chronic iron overload due to repeated blood transfusions is an acquired systemic disorder characterized by the progressive accumulation of excess iron in parenchymal tissues, occurring in patients requiring long-term transfusion therapy for chronic refractory anemias such as beta-thalassemia, sickle cell disease, or myelodysplastic syndromes This unbuffered reactive iron induces cellular oxidative stress and lipid peroxidation, leading to systemic organ injury, predominantly affecting the liver,...
- nih.gov
Chronic iron overload due to repeated blood transfusions is an acquired systemic disorder characterized by the progressive accumulation of excess iron in parenchymal tissues, occurring in patients requiring long-term transfusion therapy for chronic refractory anemias such as beta-thalassemia, sickle cell disease, or myelodysplastic syndromes If left untreated, the cumulative toxicity can cause severe end-organ complications, including hepatic fibrosis or cirrhosis, cardiac dysrhythmias and heart...
- nih.gov
Because the human body lacks an active physiologic excretion pathway for excess iron, repeated infusions of donor erythrocytes eventually saturate serum transferrin, resulting in circulating non-transferrin-bound iron
- nih.gov
Because the human body lacks an active physiologic excretion pathway for excess iron, repeated infusions of donor erythrocytes eventually saturate serum transferrin, resulting in circulating non-transferrin-bound iron This unbuffered reactive iron induces cellular oxidative stress and lipid peroxidation, leading to systemic organ injury, predominantly affecting the liver, myocardium, and endocrine glands
Personalize your experience
Follow Chronic iron overload due to repeated blood transfusions and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.